Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
Holding SLRX?
Track your performance easily
SLRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.26 - $7.44
Previous Close$1.67
Volume70.34K
Average Volume (3M)789.91K
Market Cap
$2.41M
Enterprise Value-$866.09K
Total Cash (Recent Filing)$3.27M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Mar 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.64
Shares Outstanding1,441,157
10 Day Avg. Volume1,836,958
30 Day Avg. Volume789,911
Standard Deviation0.24
R-Squared0.04
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)1.01
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Salarius Pharmaceuticals News
Ownership Overview
5.99%
Insiders
0.13% Mutual Funds
1.58% Other Institutional Investors
91.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SLRX FAQ
What was Salarius Pharmaceuticals Inc’s price range in the past 12 months?
Salarius Pharmaceuticals Inc lowest stock price was $1.26 and its highest was $7.44 in the past 12 months.
What is Salarius Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Salarius Pharmaceuticals Inc’s upcoming earnings report date?
Salarius Pharmaceuticals Inc’s upcoming earnings report date is Mar 31, 2025 which is in 141 days.
How were Salarius Pharmaceuticals Inc’s earnings last quarter?
Salarius Pharmaceuticals Inc released its earnings results on Aug 07, 2024. The company reported -$2.37 earnings per share for the quarter, beating the consensus estimate of -$53.6 by $51.23.
Is Salarius Pharmaceuticals Inc overvalued?
According to Wall Street analysts Salarius Pharmaceuticals Inc’s price is currently Overvalued.
Does Salarius Pharmaceuticals Inc pay dividends?
Salarius Pharmaceuticals Inc does not currently pay dividends.
What is Salarius Pharmaceuticals Inc’s EPS estimate?
Salarius Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Salarius Pharmaceuticals Inc have?
Salarius Pharmaceuticals Inc has 1,441,157 shares outstanding.
What happened to Salarius Pharmaceuticals Inc’s price movement after its last earnings report?
Salarius Pharmaceuticals Inc reported an EPS of -$2.37 in its last earnings report, beating expectations of -$53.6. Following the earnings report the stock price went up 26.882%.
Which hedge fund is a major shareholder of Salarius Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in SLRX
---
Salarius Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.20%
12-Months-Change
Fundamentals
Return on Equity
-119.83%
Trailing 12-Months
Asset Growth
-70.52%
Trailing 12-Months
Company Description
Salarius Pharmaceuticals Inc
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius' clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company is headquartered in Houston, TX.
---
SLRX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---